Episode 7: CEO Insights: Immunotherapy Innovations, AI Challenges and Clinical Trial Observations In our new episode CEO Insights: Immunotherapy Innovations, AI Challenges and Clinical Trial Observations, our CEO & Founder, Alan Vanderborght, sits down with David Apelian, CEO at Theolytics. Together, they explore various current industry topics, focusing on exciting immunotherapy innovations, AI pros and cons and […]
